ISRCTN83308122已完成不适用
Six-month clinical trial to investigate the effect of Hintonia latiflora in the dietetic treatment of mild and moderate type 2 diabetes mellitus
Gehrlicher Pharmazeutische Extrakte GmbH (Germany)0 个研究点目标入组 40 人开始时间: 2012年9月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Type 2 diabetics
- •2. Between the ages of 45 and 80
- •3. Neither oral antidiabetic agents nor insulin were used
- •4. Prescribed diet had led to stable but not nearly normoglycaemic values
- •As a condition for inclusion in the study, diabetic symptoms must have existed for a period of at least 12 months. The values for fasting blood sugar had to be in the range from 7-14 mmol/l (normal value: 3.9-5.4 mmol/l).
排除标准
- •To be excluded were patients for whom there was a doubt about the reliability with respect to the adherence to the dietetic guidelines (e.g., with regard to alcohol consumption). Other exclusion reasons were severe diabetic symptoms, progressive life-threatening diseases, hepatic dysfunction or renal insufficiency (deviations of GOT, ?GT and AP of more than twice the normal value, serum creatinine > 130 µmol/l), hypoglycaemic crises not noticed in time, retinopathy, pregnancy, malignant tumours and/or drug or alcohol dependence in the medical history.
研究者
相似试验
已完成
不适用
Clinical trial to evaluate the influence of 6 day-dexamethasone (inducer of CES1)Diseases of th respiratory systemKCT0001533Bundang CHA General Hospital20
已完成
2 期
Randomized trial of clinical effect of 6 months or 3months Gn-RH agonist (Goserelin acetate 1.8mg) to endometriosis comlicated uterine myomaJPRN-UMIN000026073Department of Obstetrics and Gynecology Nara Medical University80
已完成
不适用
Effectiveness of a Herbal and Nutritional Supplement on Cognitive Function in Older Adults with Subjective Cognitive ImpairmentACTRN12617000945325Mrs Adele Cave100
进行中（未招募）
1 期
Efficacy study to evaluate fluticasone furoate /vilanterol Inhalation Powder delivered once daily via the Dry Powder Inhaler Ellipta™ compared with usual ICS/LABA maintenance therapy delivered by Dry Powder Inhaler in subjects with Persistent AsthmaSubject with persistent asthmaMedDRA version: 19.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-000551-81-DEGlaxoSmithKline Research & Development Limited422
招募中
不适用
Clinical study over a period of at least 6 months to an individualized strength and endurance training in COPD patients in MarburgerJ44.8Other specified chronic obstructive pulmonary diseaseDRKS00006842Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Germany, Member of the German Center for Lung Research (DZL)48